Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by National Institute of Allergy and Infectious Diseases (NIAID)
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT01828073
First received: April 5, 2013
Last updated: February 1, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2019 (Final data collection date for primary outcome measure)